Echo intensity of the rectus femoris in stable COPD patients

International Journal of COPD

Volumn 12, Issue , 2017, Pages 3007-3015

  Ye, Xiong ^a   Wang, Mingjie ^b   Xiao, Hui ^b  

^a SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease3; Echo intensity; Rectus femoris; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ECHO INTENSITY; ECHOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; IMAGE ANALYSIS; MALE; MUSCLE CROSS SECTIONAL AREA; MUSCLE THICKNESS; MUSCULOSKELETAL SYSTEM PARAMETERS; OUTPATIENT; PATIENT MONITORING; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; RADIOLOGICAL PARAMETERS; RECTUS FEMORIS MUSCLE; SHORT FORM 8; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

AGED; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; ULTRASONOGRAPHY; VITAL CAPACITY;

EID: 85032750104     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S143645     Document Type: Article

References (46)

1. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mecha nisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2013;45(10):2245-2256.
2. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength pre dicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115-120.
3. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71(3):733-738.
4. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quad riceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81-88.
5. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tis sue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859-867.
6. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease: an update. Clin Med. 2011;11(5):461-464.
7. Alkhuja S. Physical activity in people with COPD, using the National Health and Nutrition Evaluation Survey (NHANES) dataset (2003-2006). Heart Lung. 2013;42:483-484.
8. Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int. 2014;2014:965764.
9. Maltais F, Decramer M, Casaburi R, et al. An official American Tho racic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15-e62.
10. Hu J, Meek P. Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung. 2005;34(6):415-422.
11. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57-66.
12. Seymour JM, Ward K, Sidhu PS, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax. 2009;64(5):418-423.
13. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629-634.
14. Pillen S, van Keimpema M, Nievelstein RA, et al. Skeletal muscle ultrasonography: visual versus quantitative evaluation. Ultrasound Med Biol. 2006;32:1315-1321.
15. Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assess ment of human skeletal muscle size. Eur J Appl Physiol. 2004;91(1):116-118.
16. Mayans D, Cartwright MS, Walker FO. Neuromuscular ultrasonogra phy: quantifying muscle and nerve measurements. Phys Med Rehabil Clin N Am. 2012;23(1):133-148, xii.
17. Fukumoto Y, Ikezoe T, Yamada Y, et al. Skeletal muscle quality assessed from echo intensity is associated with muscle strength of middle-aged and elderly persons. Eur J Appl Physiol. 2012;112(4):1519-1525.
18. Jansson SA, Backman H, Stenling A, Lindberg A, Rönmark E, Lundbäck B. Health economic costs of COPD in Sweden by disease severity-has it changed during a ten years period? Respir Med. 2013;107(12):1931-1938.
19. Lâm HT, Ekerljung L, T Formula See Text Ng NF, Rönmark E, Larsson K, Lundbäck B. Prevalence of COPD by disease severity in men and women in northern Vietnam. COPD. 2014;11(5):575-581.
20. Lindberg A, Sawalha S, Hedman L, Larsson LG, Lundbäck B, Rönmark E. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Respir Med. 2015;109(1):88-95.
21. Lindberg A, Lundback B. The obstructive lung disease in Northern Sweden chronic obstructive pulmonary disease study: design, the first year participation and mortality. Clin Respir J. 2008;2(suppl 1):64-71.
22. Standardization of Spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136.
23. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
24. Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009;103(2):216-223.
25. Stridsman C, Lindberg A, Skar L. Fatigue in chronic obstructive pul monary disease: a qualitative study of people’s experiences. Scand J Caring Sci. 2014;28(1):130-138.
26. Webster K, Cella D, Yost K. The functional assessment of chronic ill ness therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
27. Arts IM, Pillen S, Schelhaas HJ, Overeem S, Zwarts MJ. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve. 2010;41(1):32-41.
28. Cartwright MS, Kwayisi G, Griffin LP, et al. Quantitative neuromus cular ultrasound in the intensive care unit. Muscle Nerve. 2013;47(2):255-259.
29. Pillen S, van Dijk JP, Weijers G, Raijmann W, de Korte CL, Zwarts MJ. Quantitative gray-scale analysis in skeletal muscle ultrasound: a com parison study of two ultrasound devices. Muscle Nerve. 2009;39(6):781-786.
30. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40:1115-1122.
31. Mathur S, Brooks D, Carvalho CR. Structural alterations of skeletal muscle in copd. Front Physiol. 2014;5:104.
32. Shields GS, Coissi GS, Jimenez-Royo P, et al. Bioenergetic abnormalities and intermuscular fat in chronic obstructive pulmonary disease (COPD)-associated quadriceps weakness. Muscle Nerve. 2015;51(2):214-221.
33. Maddocks M, Shrikrishna D, Vitoriano S, et al. Skeletal muscle adipos ity is associated with physical activity, exercise capacity and fibre shift in COPD. Eur Respir J. 2014;44(5):1188-1198.
34. Pillen S, van Alfen N, Zwarts MJ. Muscle ultrasound: a grown-up technique for children with neuromuscular disorders. Muscle Nerve. 2008;38:1213-1214.
35. Gdynia HJ, Müller HP, Ludolph AC, Köninger H, Huber R. Quantita tive muscle ultrasound in neuromuscular disorders using the parameters ‘intensity’, ‘entropy’, and ‘fractal dimension’. Eur J Neurol. 2009;16(10):1151-1158.
36. Rech A, Radaelli R, Goltz FR, da Rosa LH, Schneider CD, Pinto RS. Echo intensity is negatively associated with functional capacity in older women. Age (Dordr). 2014;36(5):9708.
37. Pillen S, Tak RO, Zwarts MJ, et al. Skeletal muscle ultrasound: correla tion between fibrous tissue and echo intensity. Ultrasound Med Biol. 2009;35:443-446.
38. Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Neuromuscul Disord. 2012;22(4):306-317.
39. Lefante JJ Jr, Harmon GN, Ashby KM, Barnard D, Webber LS. Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP). Qual Life Res. 2005;14(3):665-673.
40. Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56.
41. de Torres JP, Casanova C, Hernandez C, et al. Gender associated dif ferences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes. 2006;4:72.
42. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767-1774.
43. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-778.
44. Lewko A, Bidgood PL, Garrod R. Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulm Med. 2009;9:47.
45. Bargfrede M, Schwennicke A, Tumani H, Reimers CD. Quantitative ultrasonography in focal neuropathies as compared to clinical and EMG findings. Eur J Ultrasound. 1999;10(1):21-29.
46. Watanabe Y, Yamada Y, Fukumoto Y, et al. Echo intensity obtained from ultrasonography images reflecting muscle strength in elderly men. Clin Interv Aging. 2013;8:993-998.